Filing Details
- Accession Number:
- 0001477932-23-006714
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-07 15:53:16
- Reporting Period:
- 2023-07-17
- Accepted Time:
- 2023-09-07 15:53:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924515 | Guided Therapeutics Inc | GTHP | Electromedical & Electrotherapeutic Apparatus (3845) | 582029543 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1348439 | E John Imhoff | 5835 Peachtree Corners East Suite B Peachtree Corners GA 30092 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-17 | 26,301 | $0.00 | 4,436,637 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2023-08-11 | 500,899 | $0.00 | 4,937,536 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-08-21 | 112,568 | $0.00 | 5,050,104 | No | 4 | J | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | P | Direct | |
| No | 4 | J | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series E Preferred Stock | Acquisiton | 2023-08-11 | 250 | $0.00 | 1,000,000 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 250 | 2023-08-11 | No | 4 | P | Direct |
Footnotes
- These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2139.
- These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)).
- These securities consist of Series E Convertible Preferred Stock ("Series E Preferred") of the Issuer that are presently convertible on a 1-for-4,000 basis into Common Stock without payment or further consideration. The Series E Preferred shares are convertible at any time until 8/21/2025. The Series E Preferred has no expiration date.
- These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777.
Billionaire Hedge Funds
